Diagnósticos da América S.A Asset Resilience Ratio
Diagnósticos da América S.A asset resilience ratio. Diagnósticos da América S.A (DASA3) has an Asset Resilience Ratio of 10.42% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See DASA3 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Diagnósticos da América S.A (2000–2024)
Asset resilience ratio of Diagnósticos da América S.A from 2000 to 2024. This chart shows how Diagnósticos da América S.A's Asset Resilience Ratio has changed over time. Read total liabilities of Diagnósticos da América S.A for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Diagnósticos da América S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Diagnósticos da América S.A's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$2.20 Billion | 10.42% |
| Short-term Investments | R$0.00 | 0% |
| Total Liquid Assets | R$2.20 Billion | 10.42% |
Asset Resilience Insights
- Moderate Liquidity: Diagnósticos da América S.A has 10.42% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Diagnósticos da América S.A Industry Peers by Asset Resilience Ratio
Compare Diagnósticos da América S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.16% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
Diagnostics & Research | 70.50% |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA |
Diagnostics & Research | 9.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Diagnósticos da América S.A Asset Resilience Ratio by Year (2000–2024)
Diagnósticos da América S.A asset resilience ratio by year from 2000 to 2024. The table below shows the annual Asset Resilience Ratio data for Diagnósticos da América S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.54% | R$1.73 Billion ≈ $339.67 Million |
R$26.46 Billion ≈ $5.19 Billion |
+1.87pp |
| 2023-12-31 | 4.68% | R$1.23 Billion ≈ $240.53 Million |
R$26.21 Billion ≈ $5.14 Billion |
-5.30pp |
| 2022-12-31 | 9.98% | R$2.68 Billion ≈ $525.73 Million |
R$26.84 Billion ≈ $5.27 Billion |
-4.23pp |
| 2021-12-31 | 14.21% | R$3.30 Billion ≈ $648.25 Million |
R$23.25 Billion ≈ $4.56 Billion |
+3.46pp |
| 2020-12-31 | 10.75% | R$1.43 Billion ≈ $281.39 Million |
R$13.34 Billion ≈ $2.62 Billion |
+1.13pp |
| 2019-12-31 | 9.62% | R$850.52 Million ≈ $166.89 Million |
R$8.84 Billion ≈ $1.73 Billion |
-4.99pp |
| 2018-12-31 | 14.61% | R$1.06 Billion ≈ $207.08 Million |
R$7.22 Billion ≈ $1.42 Billion |
+5.30pp |
| 2017-12-31 | 9.31% | R$581.66 Million ≈ $114.13 Million |
R$6.25 Billion ≈ $1.23 Billion |
-3.24pp |
| 2016-12-31 | 12.55% | R$648.00 Million ≈ $127.15 Million |
R$5.16 Billion ≈ $1.01 Billion |
+9.14pp |
| 2015-12-31 | 3.41% | R$159.56 Million ≈ $31.31 Million |
R$4.68 Billion ≈ $918.65 Million |
-0.18pp |
| 2014-12-31 | 3.58% | R$165.24 Million ≈ $32.42 Million |
R$4.61 Billion ≈ $904.47 Million |
+2.03pp |
| 2013-12-31 | 1.56% | R$72.98 Million ≈ $14.32 Million |
R$4.69 Billion ≈ $920.62 Million |
+0.81pp |
| 2012-12-31 | 0.75% | R$31.95 Million ≈ $6.27 Million |
R$4.27 Billion ≈ $838.28 Million |
-0.22pp |
| 2011-12-31 | 0.97% | R$41.37 Million ≈ $8.12 Million |
R$4.28 Billion ≈ $840.36 Million |
-1.58pp |
| 2010-12-31 | 2.54% | R$49.46 Million ≈ $9.70 Million |
R$1.94 Billion ≈ $381.63 Million |
-13.98pp |
| 2009-12-31 | 16.52% | R$273.70 Million ≈ $53.71 Million |
R$1.66 Billion ≈ $325.11 Million |
-9.36pp |
| 2008-12-31 | 25.88% | R$478.75 Million ≈ $93.94 Million |
R$1.85 Billion ≈ $362.95 Million |
+23.96pp |
| 2007-12-31 | 1.92% | R$23.40 Million ≈ $4.59 Million |
R$1.22 Billion ≈ $239.08 Million |
-30.03pp |
| 2006-12-31 | 31.95% | R$325.49 Million ≈ $63.87 Million |
R$1.02 Billion ≈ $199.88 Million |
+23.72pp |
| 2005-12-31 | 8.23% | R$48.17 Million ≈ $9.45 Million |
R$585.13 Million ≈ $114.81 Million |
-14.95pp |
| 2004-12-31 | 23.19% | R$123.25 Million ≈ $24.18 Million |
R$531.60 Million ≈ $104.31 Million |
+16.09pp |
| 2003-12-31 | 7.09% | R$25.15 Million ≈ $4.94 Million |
R$354.72 Million ≈ $69.60 Million |
-3.23pp |
| 2002-12-31 | 10.32% | R$33.94 Million ≈ $6.66 Million |
R$328.84 Million ≈ $64.52 Million |
+4.96pp |
| 2001-12-31 | 5.36% | R$14.11 Million ≈ $2.77 Million |
R$263.43 Million ≈ $51.69 Million |
+5.30pp |
| 2000-12-31 | 0.06% | R$87.00K ≈ $17.07K |
R$158.04 Million ≈ $31.01 Million |
-- |
About Diagnósticos da América S.A
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care c… Read more